+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Ankylosing Spondylitis Market and Competitive Landscape - 2020

  • ID: 5023583
  • Report
  • April 2020
  • Region: Europe
  • Fore Pharma
1 of 2
The research report Europe Ankylosing Spondylitis Market and Competitive Landscape - 2020, provides comprehensive insights into the Ankylosing Spondylitis pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Ankylosing Spondylitis market size and drug sales. It also provides insights into Ankylosing Spondylitis epidemiology and late stage pipeline.

This research covers the following: Ankylosing Spondylitis treatment options, Ankylosing Spondylitis late stage clinical trials pipeline, Ankylosing Spondylitis prevalence by countries, Ankylosing Spondylitis market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).

Research Scope:
  • Countries: Germany, France, Italy, Spain, UK, Europe
  • Ankylosing Spondylitis pipeline: Find out drugs in clinical trials for the treatment of Ankylosing Spondylitis by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Ankylosing Spondylitis epidemiology: Find out the number of patients diagnosed (prevalence) with Ankylosing Spondylitis by countries
  • Ankylosing Spondylitis drugs: Identify key drugs marketed and prescribed for Ankylosing Spondylitis in the US, including trade name, molecule name, and company
  • Ankylosing Spondylitis drugs sales: Find out the sales value for Ankylosing Spondylitis drugs by countries
  • Ankylosing Spondylitis market valuations: Find out the market size for Ankylosing Spondylitis drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Ankylosing Spondylitis drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
  • Evaluate commercial market opportunities for Ankylosing Spondylitis drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Ankylosing Spondylitis market
  • Develop in-depth knowledge of competition and markets
  • Analyze Ankylosing Spondylitis drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Ankylosing Spondylitis market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies

This report will be delivered within 2 business days.
Note: Product cover images may vary from those shown
2 of 2
1. Ankylosing Spondylitis Treatment Options

2. Ankylosing Spondylitis Pipeline Insights
2.1. Ankylosing Spondylitis Phase 3 Clinical Trials
2.2. Ankylosing Spondylitis Phase 2 Clinical Trials
2.3. Ankylosing Spondylitis Phase 1 Clinical Trials

3. Ankylosing Spondylitis Epidemiology Analysis by Countries

4. Germany Ankylosing Spondylitis Market Insights
4.1. Marketed Drugs for Ankylosing Spondylitis in Germany
4.2. Germany Ankylosing Spondylitis Market Size & Forecast
4.3. Germany Ankylosing Spondylitis Drugs Sales Forecast
4.4. Germany Ankylosing Spondylitis Market Share Analysis

5. France Ankylosing Spondylitis Market Insights
5.1. Marketed Drugs for Ankylosing Spondylitis in France
5.2. France Ankylosing Spondylitis Market Size & Forecast
5.3. France Ankylosing Spondylitis Product Sales Forecast
5.4. France Ankylosing Spondylitis Market Share Analysis

6. Italy Ankylosing Spondylitis Market Insights
6.1. Marketed Drugs for Ankylosing Spondylitis in Italy
6.2. Italy Ankylosing Spondylitis Market Size & Forecast
6.3. Italy Ankylosing Spondylitis Product Sales Forecast
6.4. Italy Ankylosing Spondylitis Market Share Analysis

7. Spain Ankylosing Spondylitis Market Insights
7.1. Marketed Drugs for Ankylosing Spondylitis in Spain
7.2. Spain Ankylosing Spondylitis Market Size & Forecast
7.3. Spain Ankylosing Spondylitis Product Sales Forecast
7.4. Spain Ankylosing Spondylitis Market Share Analysis

8. UK Ankylosing Spondylitis Market Insights
8.1. Marketed Drugs for Ankylosing Spondylitis in UK
8.2. UK Ankylosing Spondylitis Market Size & Forecast
8.3. UK Ankylosing Spondylitis Product Sales Forecast
8.4. UK Ankylosing Spondylitis Market Share Analysis

9. Europe Ankylosing Spondylitis Market Insights
9.1. Europe Ankylosing Spondylitis Market Size & Forecast
9.2. Europe Ankylosing Spondylitis Product Sales Forecast
9.3. Europe Ankylosing Spondylitis Market Share Analysis

10. Research Methodology

List of Tables
Table 1: Ankylosing Spondylitis Phase 3 Clinical Trials, Global, 2020
Table 2: Ankylosing Spondylitis Phase 2 Clinical Trials, Global, 2020
Table 3: Ankylosing Spondylitis Phase 1 Clinical Trials, Global, 2020
Table 4: Ankylosing Spondylitis Prevalence by Countries, 2016 - 2024
Table 5: Marketed Drugs for Ankylosing Spondylitis in Germany, 2019
Table 6: Germany Ankylosing Spondylitis Market Size & Forecast ($mn), 2016 - 2024
Table 7: Germany Ankylosing Spondylitis Product Sales ($mn), 2016 - 2024
Table 8: Germany Ankylosing Spondylitis Market Events and Trends, 2016 - 2024
Table 9: Marketed Drugs for Ankylosing Spondylitis in France, 2019
Table 10: France Ankylosing Spondylitis Market Size & Forecast ($mn), 2016 - 2024
Table 11: France Ankylosing Spondylitis Product Sales ($mn), 2016 - 2024
Table 12: France Ankylosing Spondylitis Market Events and Trends, 2016 - 2024
Table 13: Marketed Drugs for Ankylosing Spondylitis in Italy, 2019
Table 14: Italy Ankylosing Spondylitis Market Size & Forecast ($mn), 2016 - 2024
Table 15: Italy Ankylosing Spondylitis Product Sales ($mn), 2016 - 2024
Table 16: Italy Ankylosing Spondylitis Market Events and Trends, 2016 - 2024
Table 17: Marketed Drugs for Ankylosing Spondylitis in Spain, 2019
Table 18: Spain Ankylosing Spondylitis Market Size & Forecast ($mn), 2016 - 2024
Table 19: Spain Ankylosing Spondylitis Product Sales ($mn), 2016 - 2024
Table 20: Spain Ankylosing Spondylitis Market Events and Trends, 2016 - 2024
Table 21: Marketed Drugs for Ankylosing Spondylitis in UK, 2019
Table 22: UK Ankylosing Spondylitis Market Size & Forecast ($mn), 2016 - 2024
Table 23: UK Ankylosing Spondylitis Product Sales ($mn), 2016 - 2024
Table 24: UK Ankylosing Spondylitis Market Events and Trends, 2016 - 2024
Table 25: Europe Ankylosing Spondylitis Market Size & Forecast ($mn), 2016 - 2024
Table 26: Europe Ankylosing Spondylitis Product Sales ($mn), 2016 - 2024

List of Figures
Figure 1: Ankylosing Spondylitis Pipeline by Phase (%), Global, 2020
Figure 2: Ankylosing Spondylitis Prevalence by Countries, 2016 - 2024
Figure 3: Germany Ankylosing Spondylitis Market Size ($mn), 2016 - 2024
Figure 4: Germany Ankylosing Spondylitis Product Sales ($mn), 2016 - 2024
Figure 5: Germany Ankylosing Spondylitis Market Share by Drugs (%), 2019
Figure 6: Germany Ankylosing Spondylitis Market - Future Market Share (%), 2024
Figure 7: France Ankylosing Spondylitis Market Size ($mn), 2016 - 2024
Figure 8: France Ankylosing Spondylitis Product Sales ($mn), 2016 - 2024
Figure 9: France Ankylosing Spondylitis Market Share by Drugs (%), 2019
Figure 10: France Ankylosing Spondylitis Market - Future Market Share (%), 2024
Figure 11: Italy Ankylosing Spondylitis Market Size ($mn), 2016 - 2024
Figure 12: Italy Ankylosing Spondylitis Product Sales ($mn), 2016 - 2024
Figure 13: Italy Ankylosing Spondylitis Market Share by Drugs (%), 2019
Figure 14: Italy Ankylosing Spondylitis Market - Future Market Share (%), 2024
Figure 15: Spain Ankylosing Spondylitis Market Size ($mn), 2016 - 2024
Figure 16: Spain Ankylosing Spondylitis Product Sales ($mn), 2016 - 2024
Figure 17: Spain Ankylosing Spondylitis Market Share by Drugs (%), 2019
Figure 18: Spain Ankylosing Spondylitis Market - Future Market Share (%), 2024
Figure 19: UK Ankylosing Spondylitis Market Size ($mn), 2016 - 2024
Figure 20: UK Ankylosing Spondylitis Product Sales ($mn), 2016 - 2024
Figure 21: UK Ankylosing Spondylitis Market Share by Drugs (%), 2019
Figure 22: UK Ankylosing Spondylitis Market - Future Market Share (%), 2024
Figure 23: Europe Ankylosing Spondylitis Market Size ($mn), 2016 - 2024
Figure 24: Europe Ankylosing Spondylitis Product Sales ($mn), 2016 - 2024
Figure 25: Europe Ankylosing Spondylitis Market Share by Drugs (%), 2019
Figure 26: Europe Ankylosing Spondylitis Market - Future Market Share (%), 2024
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll